Al Hammadi’s Q1 net profit falls 47% to SAR 21.6 mln

19/04/2016 Argaam Exclusive

View other reports

 

Al Hammadi Company for Development and Investment reported a net profit of SAR 21.6 million for the first quarter of 2016, a 47.4 percent drop compared to the same quarter last year. The company attributed the drop to higher depreciation expenses and financial charges stemming from the opening of Al Hammadi Hospital Al Sweidi. Also, in Q1-2015 the company collected SAR 9.8 million as written-off debt, which resulted in a decrease in general and administrative expenses.

 

When compared to the previous quarter’s net profit of SAR 35.8 million, the company’s net profit has dropped 39.7 percent due to closing the Al Olaya branch during Q1-2016 after an electrical contact incident on February 7.



Current Quarter Comparison (M)

Compared With The
Item Q1 2015 Q1 2016 Change‬
Revenues 129.48 144.16 11.3 %
Gross Income 50.64 54.75 8.1 %
Operating Income 33.35 26.66 (20.0 %)
Net Income 41.01 21.14 (48.5 %)
Average Shares 160.00 160.00 -
EPS (Riyals) 0.26 0.13 (48.5 %)


Financial results (Million)

Period Revenues Change Gross Income Change Net Income Change EPS(Riyal)
Q1 2007 - - - - - - -
Q2 2007 - - - - - - -
Q3 2007 - - - - - - -
Q4 2007 - - - - - - -
Q1 2008 - - - - - - -
Q2 2008 - - - - - - -
Q3 2008 - - - - - - -
Q4 2008 - - - - - - -
Q1 2009 - - - - - - -
Q2 2009 - - - - - - -
Q3 2009 - - - - - - -
Q4 2009 - - - - - - -
Q1 2010 - - - - - - -
Q2 2010 - - - - - - -
Q3 2010 - - - - - - -
Q4 2010 - - - - - - -
Q1 2011 - - - - - - -
Q2 2011 - - - - - - -
Q3 2011 - - - - - - -
Q4 2011 - - - - - - -
Q1 2012 - - - - - - -
Q2 2012 - - - - - - -
Q3 2012 - - - - - - -
Q4 2012 - - - - - - -
Q1 2013 104.84 - 47.34 - 29.83 - 0.19
Q2 2013 108.85 - 45.84 - 30.06 - 0.19
Q3 2013 96.26 - 36.81 - 18.32 - 0.11
Q4 2013 124.13 - 55.17 - 33.29 - 0.21
Q1 2014 122.04 16.4 % 54.71 15.6 % 34.23 14.7 % 0.21
Q2 2014 121.66 11.8 % 53.68 17.1 % 35.60 18.4 % 0.22
Q3 2014 108.83 13.1 % 44.74 21.5 % 25.42 38.7 % 0.16
Q4 2014 129.43 4.3 % 55.99 1.5 % 33.71 1.2 % 0.21
Q1 2015 129.48 6.1 % 50.64 (7.4 %) 41.01 19.8 % 0.26
Q2 2015 137.36 12.9 % 63.56 18.4 % 36.89 3.6 % 0.23
Q3 2015 136.80 25.7 % 57.97 29.6 % 27.69 8.9 % 0.17
Q4 2015 157.70 21.8 % 68.06 21.6 % 35.75 6.0 % 0.22
Q1 2016 144.16 11.3 % 54.75 8.1 % 21.14 (48.5 %) 0.13

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2007 - - -
Q2 2007 - - -
Q3 2007 - - -
Q4 2007 - - -
Q1 2008 - - -
Q2 2008 - - -
Q3 2008 - - -
Q4 2008 - - -
Q1 2009 - - -
Q2 2009 - - -
Q3 2009 - - -
Q4 2009 - - -
Q1 2010 - - -
Q2 2010 - - -
Q3 2010 - - -
Q4 2010 - - -
Q1 2011 - - -
Q2 2011 - - -
Q3 2011 - - -
Q4 2011 - - -
Q1 2012 - - -
Q2 2012 - - -
Q3 2012 - - -
Q4 2012 - - -
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 42.66 % 27.60 % 24.31 %
Q1 2014 42.66 % 27.85 % 24.35 %
Q2 2014 43.18 % 29.90 % 26.17 %
Q3 2014 43.70 % 30.34 % 26.97 %
Q4 2014 43.39 % 30.09 % 26.75 %
Q1 2015 41.90 % 29.13 % 25.73 %
Q2 2015 42.55 % 28.68 % 25.19 %
Q3 2015 42.80 % 29.71 % 24.29 %
Q4 2015 42.80 % 31.06 % 23.43 %
Q1 2016 42.42 % 30.79 % 21.09 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2007 - - - -
Q2 2007 - - - -
Q3 2007 - - - -
Q4 2007 - - - -
Q1 2008 - - - -
Q2 2008 - - - -
Q3 2008 - - - -
Q4 2008 - - - -
Q1 2009 - - - -
Q2 2009 - - - -
Q3 2009 - - - -
Q4 2009 - - - -
Q1 2010 - - - -
Q2 2010 - - - -
Q3 2010 - - - -
Q4 2010 - - - -
Q1 2011 - - - -
Q2 2011 - - - -
Q3 2011 - - - -
Q4 2011 - - - -
Q1 2012 - - - -
Q2 2012 - - - -
Q3 2012 - - - -
Q4 2012 - - - -
Q1 2013 160.00 - - 3.74
Q2 2013 160.00 - - 3.67
Q3 2013 160.00 - - 3.78
Q4 2013 160.00 0.70 0.66 3.66
Q1 2014 160.00 0.72 0.69 3.87
Q2 2014 160.00 0.76 0.76 7.88
Q3 2014 160.00 0.80 0.80 8.04
Q4 2014 160.00 0.81 0.81 8.25
Q1 2015 160.00 0.85 0.79 8.51
Q2 2015 160.00 0.86 0.80 8.27
Q3 2015 160.00 0.87 0.81 8.44
Q4 2015 160.00 0.88 0.82 8.66
Q1 2016 160.00 0.76 0.76 8.80

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2007 - - -
Q2 2007 - - -
Q3 2007 - - -
Q4 2007 - - -
Q1 2008 - - -
Q2 2008 - - -
Q3 2008 - - -
Q4 2008 - - -
Q1 2009 - - -
Q2 2009 - - -
Q3 2009 - - -
Q4 2009 - - -
Q1 2010 - - -
Q2 2010 - - -
Q3 2010 - - -
Q4 2010 - - -
Q1 2011 - - -
Q2 2011 - - -
Q3 2011 - - -
Q4 2011 - - -
Q1 2012 - - -
Q2 2012 - - -
Q3 2012 - - -
Q4 2012 - - -
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 51.42 51.42 5.14
Q4 2014 48.92 48.92 4.78
Q1 2015 51.53 55.54 5.14
Q2 2015 54.13 58.30 5.61
Q3 2015 44.33 47.69 4.57
Q4 2015 41.63 44.73 4.24
Q1 2016 36.41 36.41 3.14

Business Segments (Million)

Compared With The
Period healthy services and other Pharmaceutical sales revenue - Pharmacies

Analysts Estimates (Million)

Item Q1 2016 (e) Q1 2016 (a) Change‬
Average 34.03 21.14 (37.9 %)

Estimates vs Actual (Million)

Item Q1 2016 (e) Q1 2016 (a) Change
Al Rajhi Capital 27.00 21.14 (21.7) %
OSOOL AND BAKHEET 30.70 21.14 (31.2) %
Alistithmar Capital 31.90 21.14 (33.7) %
AlJazira Capital 34.00 21.14 (37.8) %
Albilad Capital 35.00 21.14 (39.6) %
KASB Capital 45.60 21.14 (53.7) %

Current
Market Cap (M Riyal) 7,512.00
Enterprise Value (EV) (M) 7,510.11
Shares Outstanding ((M)) 160.00
EPS ( Riyal) (TTM) 1.79
Book Value (BV) ( Riyal) 11.58
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 26.88
P/E (TTM) 26.27
Price/book 4.05
Return on Average Assets (%) (TTM) 11.1
Return on Average Equity (%) (TTM) 15.9

Share Price

46.95
(1.20) (2.49 %)

Al Hammadi Holding (ALHAMMADI)


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.